Fetal and Neonatal Alloimmune Thrombocytopenia
Hematology
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
RallybioAnti-
RallybioClinical data collection
Clinical Trials (2)
Total enrollment: 14,391 patients across 2 trials
Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization
Start: Nov 2024Est. completion: Oct 20251 patients
Phase 2Terminated
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Start: Mar 2022Est. completion: Oct 202514,390 patients
N/ACompleted
Related Jobs in Hematology
MSL Hematología L - Sur
Johnson & Johnson
Sevilla, Spain
2d ago
Senior Manager – Strategy & Business Transformation
Johnson & Johnson
Mumbai, India
2d ago
Délégué Médical LLC/Myélome (H/F) - secteurToulouse
Johnson & Johnson
Issy-les-Moulineaux, France
2d ago
Sr. Director Marketing
Genetix Biotherapeutics
Somerville, Massachusetts, United States
4d ago
From $270K/yr
SALES REP SR - Hematologia (Ribeirão Preto/Sorocaba)
Novartis
Santo Amaro
5d ago
Hematology Field Medical Director, non-MD
Pfizer
Remote
5d ago
$177K - $294K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space